Management of Newly Diagnosed HIV Infection
Authors: Judith Feinberg
Journal: Annals of Internal Medicine (2011)

In the Clinic4 October 2011Management of Newly Diagnosed HIV InfectionDeborah Cotton, MD, MPH, Darren Taichman, MD, PhD, Sankey Williams, MD, and Judith Feinberg, MDDeborah Cotton, MD, MPHSearch for more papers by this author, Darren Taichman, MD, PhDSearch for more papers by this author, Sankey Williams, MDSearch for more papers by this author, and Judith Feinberg, MDSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-155-7-201110040-01004 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail No field in medicine has moved as swiftly as that of HIV/AIDS over the past 30 years. As a consequence, many studies are out of date by the time of publication. Because of the rapid turnover of key information, this In the Clinic focuses on the essential principles of care for the newly diagnosed adult with HIV-1 infection. To ensure continued usefulness, the general directions in which this field is moving and how to access updated information are emphasized.Studies have demonstrated that positive clinical outcomes are a function of the clinician's experience in caring for HIV-infected individuals (1, 2). ...References1. Kitahata MM, Koepsell TD, Deyo RA, Maxwell CL, Dodge WT, Wagner EH. Physicians' experience with the acquired immunodeficiency syndrome as a factor in patients' survival. N Engl J Med. 1996;334:701-6. [PMID: 8594430] Google Scholar2. Kitahata MM, Van Rompaey SE, Shields AW. Physician experience in the care of HIV-infected persons is associated with earlier adoption of new antiretroviral therapy. J Acq Immune Deficiency Syndrome. 2000; 24; 2:106-14. [PMID: 10935685] Google Scholar3. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med. 1998;338:853-60. [PMID: 9516219] Google Scholar4. CDC. HIV surveillance- United States, 1981-2008. MMWR Morb Mortal Wkly Rep. 2011;60:689-93. [PMID: 21796096] Google Scholar5. Chou R, Huffman L. Screening for human immunodeficiency virus: focused update of a 2005 systematic evidence review for the U.S. Preventive Services Task Force. Rockville, MD: Agency for Healthcare Research and Quality; 2007. AHRQ publication no. 07-0597-EF-1; 19 Google Scholar6. Jenkins TC, Gardner EM, Thrun MW, Cohn DL, Burman WJ. Risk-based human immunodeficiency virus (HIV) testing fails to detect the majority of HIV-infected persons in medical care Settings. Sex Transm Dis. 2006;33:329-33. [PMID: 16547450] Google Scholar7. CDC. Revised Recommendations for HIV Testing of Adults, Adolescents and Pregnant Women in Health-care Settings. MMWR Recomm Rep. 2006;55(RR-14):1-17. [PMID: 16988643] Google Scholar8. Bartlett JG, Branson BM, Fenton K, et al. Opt-out testing for human immunodeficiency virus in the United States: progress and challenges. JAMA. 2008;300:945-51. [PMID: 18728268] Google Scholar9. Public Health Service Task Force. Recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States. Available at: http://aidsinfo.nih.gov/ContentFiles/PerinatalGL.pdf. Google Scholar10. Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis. MMWR Recomm Rep. 2001;50(RR-11):1-52. [PMID:11442229] Google Scholar11. CDC. Prevalence and awareness of HIV infection among men who have sex with men—21 cities, United States, 2008, 2008. MMWR. 2010;59:1201-7. [PMID: 20864920] Google Scholar12. U.S. Preventive Services Task Force. Screening for HIV: recommendation statement. Rockville, MD: Agency for Healthcare Research and Quality; July 2005, amended 2 April 2007. AHRQ publication no. 07-0597-EF-2. Google Scholar13. CDC. Update: serologic testing for HIV-1 antibody—United States, 1988 and 1989. MMWR. 1990; 39:380-3. [PMID: 2111436] Google Scholar14. Kleinman S, Busch MP, Hall L, et al. False-positive HIV-1 test results in a low-risk screening setting of voluntary blood donation. Retrovirus Epidemiology Donor Study. JAMA. 1998; 280:1080-5. [PMID: 9757856] Google Scholar15. CDC. False-positive oral fluid rapid HIV tests—New York City, 2005-2008.MMWR Morb Mortal Wkly Rep. 2008;57;660-5. [PMID: 18566566] Google Scholar16. Kahn JO, Walker BD. Acute human immunodeficiency virus type 1 infection. N Engl J Med. 1998;339:33-9. [PMID: 9647878] Google Scholar17. Weintrob AC, Giner J, Menezes P, et al. Infrequent diagnosis of primary human immunodeficiency virus infection: missed opportunities in acute care settings. Arch Intern Med. 2003;163:2097-100. [PMID: 14504125] Google Scholar18. Coco A, Kleinhans E. Prevalence of primary HIV infection in symptomatic ambulatory patients. Ann Fam Med. 2005; 3:400-4. [PMID: 16189055] Google Scholar19. Wawer MJ, Gray RH, Sewankambo NK, et al. Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. J Infect Dis. 2005;191:1403-9. [PMID: 15809897] Google Scholar20. CDC. Late versus early testing of HIV-16 sites, United States, 2000-2003. MMWR 2003;52:581-6. [PMID: 12836626] Google Scholar21. National Center for Infectious Diseases Division of HIV/AIDS. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992; 41(RR-17):1-19. [PMID: 1361652] Google Scholar22. Mellors JW, Rinaldo CR Jr, Gupta P, White RM, Todd JA, Kingsley LA. Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science. 1996;272:1167-70. [PMID: 8638160] Google Scholar23. Mellors JW, Mu–oz A, Giorgi JV, Margolick JB, Tassoni CJ, Gupta P, et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med. 1997;126:946-54. [PMID: 9182471] Google Scholar24. Aberg JA, Kaplan JE, Libman H, Emmanuel P, Anderson JR, Stone VE, et al; HIV Medicine Association of the Infectious Diseases Society of America. Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2009;49:651-81. [PMID: 19640227] Google Scholar25. Castilla J, Del Romero J, Hernando V, Marincovich B, Garc'a S, Rodr'guez C. Effectiveness of highly active antiretroviral therapy in reducing heterosexual transmission of HIV. J Acquir Immune Defic Syndr. 2005;40:96-101. [PMID: 16123689] Google Scholar26. Cohen MS, Chen YQ, McCauley M, et al; HPTN 052 Study Team. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365:493-505. [PMID: 21767103] Google Scholar27. Adult Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. January 10, 2011; 1–166. Available at: www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf. Google Scholar28. The Strategies for Management of Antiretroviral Therapy (SMART) Study Group. CD4 count-guided interruption of antiretroviral therapy. N Engl J Med. 2006; 355(2283-96). [PMID: 17135583] Google Scholar29. Severe P, Juste MA, Ambroise A, Eliacin L, Marchand C, Apollon S, et al. Early versus standard antiretroviral therapy for HIV-infected adults in Haiti. N Engl J Med. 2010;363:257-65. [PMID: 20647201] Google Scholar30. Lewden C, Chene G, Morlat P, Raffi F, Dupon M, Dellamonica P, et al; Agence Nationale de Recherches sur le Sida et les Hepatites Virales (ANRS) CO8 APROCO-COPILOTE Study Group. HIV-infected adults with a CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population. J Acquir Immune Defic Syndr. 2007;46:72-7. [PMID: 17621240] Google Scholar31. Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents. Recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR. 2009;58:1-166. [PMID: 19730409] Google Scholar32. Grant RM, Lama JR, Anderson PL, et al; iPrEx Study Team. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363:2587-99. [PMID: 21091279] Google Scholar33. Abdool Karim Q, Abdool Karim SS, Frohlich JA, Grobler AC, Baxter C, Mansoor LE, et al; CAPRISA 004 Trial Group. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329:1168-74. [PMID: 20643915] Google Scholar34. U.S. Public Health Service. Updated U.S. Public Health Service Guidelines for the Management of Occupational Exposures to HBV, HCV, and HIV and Recommendations for Postexposure Prophylaxis. MMWR. 2001;50(RR11);1-42. [PMID: 11442229] Google Scholar35. Thea DM, Steketee RW, Pliner V, Bornschlegel K, Brown T, Orloff S, et al. The effect of maternal viral load on the risk of perinatal transmission of HIV-1. New York City Perinatal HIV Transmission Collaborative Study Group. AIDS. 1997;11:437-44. [PMID: 9084790] Google Scholar36. Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States. May 24, 2010;1-117. Google Scholar37. Zolopa AR, Anderson J, Komarow L, et al. Early antiretroviral therapy reduces AIDS progression/ death in individuals with acute opportunistic infections: a multicenter randomized strategy trial. PLoS 5/18/09; PLoS ONE 4(5). Google Scholar38. Office of National AIDS Policy. National HIV/AIDS strategy. Washington, DC: Office of National AIDS Policy; 2010. Available at: www.whitehouse.gov/administration/eop/onap/nhas. Google Scholar39. New York Department of Health AIDS Institute National Quality Center and Health Resources and Services Administration HIV/AIDS Bureau. Guideline-Based Quality Indicators for HIV Care. HRSA. 2008;1-166. Google Scholar40. American Association of HIV Medicine, Washington, D.C.; 2007. Google Scholar41. American Association of HIV Medicine. Fundamentals of HIV Medicine 2010-2011 CD Update, Washington, D.C. Google Scholar Author, Article, and Disclosure InformationAffiliations: PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByGut Microbiome, Short-Chain Fatty Acids, and Mucosa Injury in Young Adults with Human Immunodeficiency Virus Infection 4 October 2011Volume 155, Issue 7Page: ITC4-1KeywordsAIDSAntibodiesAntiretroviral therapyDrugsHIVHIV infectionsHIV preventionPregnancyViral load ePublished: 4 October 2011 Issue Published: 4 October 2011 CopyrightCopyright © 2011 by American College of Physicians. All Rights Reserved.PDF DownloadLoading ...